Dear Shareholder,
We hereby inform you that the board of directors (the “Directors”) of Swiss Life Funds (LUX) (the
“Company”) intends, in accordance with Article 24 of the articles of incorporation of the Company, to liquidate the sub-fund Swiss Life Funds (LUX) - Equity Biomedical (the “Sub-Fund”) on 23 February 2011 (the “Liquidation Date”). Accordingly no new subscription into the Sub-Fund will be allowed from the date of this notice.